News / All News / Article

Weiming Penguin Recognized as a “Beijing Innovative SME” | Weiming Honors

Article images may contain Chinese text.

In August 2024, the Beijing Municipal Bureau of Economy and Information Technology organized the district authorities responsible for small and medium-sized enterprises to conduct the 2024 evaluation and recognition of Beijing Innovative SMEs. With its outstanding innovation capabilities and technological strengths, Weiming Penguin was successfully recognized as a “Beijing Innovative SME.”
Image

“Innovative SMEs” are small and medium-sized enterprises with relatively well-established innovation mechanisms, strong capabilities to innovate in products, technologies, management, and business models, a focus on niche markets, and good growth prospects. They have a high degree of specialization, strong innovation capabilities, and development potential.

Guided by its mission of “Connecting Health,” Weiming Penguin is committed to advancing digital transformation in the pharmaceutical and healthcare industry through Data+AI digital tools and professional services, helping pharmaceutical companies push beyond efficiency boundaries and achieve data-driven business growth.

Innovation and technological leadership are part of the Weiming Penguin team’s core DNA. Throughout the nine years since its founding, the company has maintained high technological standards and continuously advanced technological innovation. Looking ahead, the company will continue to integrate cutting-edge artificial intelligence technologies to further empower sales and management at healthcare companies, bringing greater innovative momentum to the industry.


Image